InvestorsHub Logo
icon url

1776club

03/08/21 1:09 PM

#8928 RE: dia76ca #8926

When I lived in New York we would say that Lee’s Pharmaceutical has the Juice to make this happen in China. The question still remains, does SOEERNTO have any Juice to make things happen in the USA? DARPA, Mayo, UPS, Brazil and others say yes, so....SHOW ME THE MONEY! Positive Cash Flow, can you give us a timeline Dr. Ji? Too much to ask?
icon url

dia76ca

03/08/21 5:39 PM

#8935 RE: dia76ca #8926

More coming from the Lee partnership!
"Dr. Henry Ji, Chairman and CEO of Sorrento Therapeutics, stated, “We at Sorrento are happy with the collaboration with our colleagues at Lee’s Pharma and are satisfied with the clinical advance of our first therapeutic antibody partnership in socazolimab. We currently plan to expand our partnership with Lee’s Pharma and are in discussions regarding the co-development of additional therapeutic antibodies from Sorrento to treat hematologic and solid tumors.”

The anti-PD-L1 is obviously another blockbuster drug. It can bring in hundreds of millions of upfront, milestone and royalty payments. Or simply be sold off for billions to finance the rest of the cancer pipline eg. ADNAB, DAR-T and plasmid DNA!